Consilium Wealth Advisory, LLC Zoetis Inc. Transaction History

Consilium Wealth Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$165.67 - $199.94 $41,748 - $50,384	-252 Reduced 7.24%	3,229 $546,000
Q4 2023 Jan 10, 2024	BUY	$151.44 - $200.09 $101,767 - $134,460	672 Added 23.92%	3,481 $687,000
Q3 2023 Oct 10, 2023	BUY	$167.14 - $192.77 $34,263 - $39,517	205 Added 7.87%	2,809 $488,000
Q2 2023 Jul 13, 2023	BUY	$160.94 - $186.23 $149,030 - $172,448	926 Added 55.18%	2,604 $448,000
Q1 2023 Apr 13, 2023	BUY	$145.48 - $175.02 $244,115 - $293,683	1,678 New	1,678 $279,000

1,896

423M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $87.4B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Consilium Wealth Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Consilium Wealth Advisory, LLC with notifications on news.